EGFR and neoplasm: In this study, we retrospectively identify the significance of the occurrence of EGFR mutations by assessing life expectancy, neurological symptoms in the disease course, and neuroimaging (to assess neoplasm and edema volume measured on FLAIR sequences) in a cohort of 81 surgically treated patients.